Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

87.11
-0.3600-0.41%
Post-market: 87.02-0.0900-0.10%19:30 EDT
Volume:1.09M
Turnover:94.72M
Market Cap:12.27B
PE:-38.14
High:88.46
Open:87.90
Low:85.94
Close:87.47
52wk High:95.49
52wk Low:20.45
Shares:140.86M
Float Shares:122.00M
Volume Ratio:1.09
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2838
EPS(LYR):-0.0122
ROE:-55.21%
ROA:-8.10%
PB:26.36
PE(LYR):-7,144.26

Loading ...

Arrowhead CMO James Hamilton disposes of 10,000 shares worth $750,000

Reuters
·
Apr 25

Arrowhead says CHMP backs EU approval of REDEMPLO for familial chylomicronemia syndrome

Reuters
·
Apr 24

Arrowhead Pharmaceuticals - Receives Positive Chmp Opinion for Redemplo (Plozasiran) in Fcs in Europe

THOMSON REUTERS
·
Apr 24

Arrowhead Pharmaceuticals - European Commission Decision on Redemplo Marketing Authorization Expected in Q2 2026

THOMSON REUTERS
·
Apr 24

This Pharma Stock Is Up 460% Over the Past Year. What Could Be Key to Future Gains. -- Barrons.com

Dow Jones
·
Apr 21

Arrowhead Pharmaceuticals To Rally Over 44%? Here Are 10 Top Analyst Forecasts For Tuesday

Benzinga_recent_news
·
Apr 21

Arrowhead Pharmaceuticals Raised to Overweight From Equal-Weight by Morgan Stanley

Dow Jones
·
Apr 21

Arrowhead Pharmaceuticals Inc : Morgan Stanley Raises to Overweight From Equal-Weight

THOMSON REUTERS
·
Apr 21

Arrowhead Pharmaceuticals Inc : Morgan Stanley Raises Target Price to $100.00 From $78.00

THOMSON REUTERS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Apr 21

Arrowhead upgraded to Overweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Apr 21

U.S. RESEARCH ROUNDUP-CNX Resources, P&G, Prologis

Reuters
·
Apr 21

Press Release: Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results

Dow Jones
·
Apr 21

Arrowhead price target raised to $93 from $81 at BofA

TIPRANKS
·
Apr 20

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Arrowhead Pharmaceuticals (ARWR) and Legend Biotech (LEGN)

TIPRANKS
·
Apr 20

Arrowhead Pharmaceuticals : Bofa Global Research Raises Price Objective to $93 From $81

THOMSON REUTERS
·
Apr 20

U.S. RESEARCH ROUNDUP-Carpenter Technology, IBM, Ulta Beauty

Reuters
·
Apr 20

Arrowhead Pharmaceuticals (ARWR) Is Up 5.9% After Durable Two-Year Plozasiran Data in Severe Hypertriglyceridemia

Simply Wall St.
·
Apr 06

Arrowhead presents long-term efficacy, safety data for plozasiran

TIPRANKS
·
Mar 30

Arrowhead says plozasiran cuts triglycerides up to 83% in two-year extension study

Reuters
·
Mar 28